Orbiepharm Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Later Stage VC
- Investors
-
8
Orbiepharm General Information
Description
Developer of pharmaceuticals and diagnostic products designed for animal health. The company's products focus on pet health, including medical diseases, chronic diseases, and geriatric diseases, and the company is the only pet medicine and health industry chain group enterprise with R&D, production, sales, and terminal hospitals in China now, enabling the animals to have more efficient diagnosis and treatment.
Contact Information
Website
www.orbiepharm.comCorporate Office
- Room 203, Haohai Building
- No. 7 Shangdi 5th Street, Haidian District
- Beijing, 100085
- China
Corporate Office
- Room 203, Haohai Building
- No. 7 Shangdi 5th Street, Haidian District
- Beijing, 100085
- China
Orbiepharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 27-Jul-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 12-Nov-2018 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 16-Mar-2016 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2013 | Completed | Generating Revenue |
Orbiepharm Patents
Orbiepharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2013026357-A1 | Preparation method of imidazole derivatives | Inactive | 25-Aug-2011 | ||
| EP-2636672-A1 | Imidazole derivatives and preparation method and use thereof | Active | 02-Nov-2010 | ||
| EP-2636672-A4 | Imidazole derivatives and preparation method and use thereof | Active | 02-Nov-2010 | ||
| EP-2636672-B1 | Imidazole derivatives and preparation method and use thereof | Active | 02-Nov-2010 | ||
| US-20130225638-A1 | Imidazole derivatives and preparation method and use thereof | Active | 02-Nov-2010 | C07D401/04 |
Orbiepharm Signals
Orbiepharm Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Jinhuitong Investment Fund Management | Growth/Expansion | Minority | ||
| Lucion Venture Capital | Venture Capital | Minority | ||
| Shandong High-tech Venture Capital | Venture Capital | Minority | ||
| CCB International Trade (Xiamen) Private Equity Fund Management | Growth/Expansion | Minority | ||
| China Cinda Asset Management | Corporation | Minority |
Orbiepharm FAQs
-
When was Orbiepharm founded?
Orbiepharm was founded in 2010.
-
Where is Orbiepharm headquartered?
Orbiepharm is headquartered in Beijing, China.
-
What is the size of Orbiepharm?
Orbiepharm has 50 total employees.
-
What industry is Orbiepharm in?
Orbiepharm’s primary industry is Pharmaceuticals.
-
Is Orbiepharm a private or public company?
Orbiepharm is a Private company.
-
What is Orbiepharm’s current revenue?
The current revenue for Orbiepharm is .
-
Who are Orbiepharm’s investors?
Beijing Jinhuitong Investment Fund Management, Lucion Venture Capital, Shandong High-tech Venture Capital, CCB International Trade (Xiamen) Private Equity Fund Management, and China Cinda Asset Management are 5 of 8 investors who have invested in Orbiepharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process